COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,575 Articles (22,415 medRxiv, 8,160 bioRxiv)

Most recent first Previous |  Page 2072: Articles 20711-20720  | Next

Patterns of Multimorbidity and Risk of Severe SARS-CoV-2 Infection: an observational study in the U.K.
Chudasama, Y. V., Zaccardi, F., Gillies, C. L., Razieh, C., Yates, T., Kloecker, D. E., Rowlands, A. V., Davies, M. J., Islam, N., Seidu, S., Forouhi, N. G., Khunti, K.
10.1101/2020.10.21.20216721 — Posted: 2020-10-23 Discussion: Onsite
Prediction of the infection of COVID-19 in Bangladesh by classical SIR model
Parvez, S. M., Tabassum, F., Ali, H. M. S., Hossain, M. M.
10.1101/2020.10.21.20216846 — Posted: 2020-10-23
No lockdown policy for COVID-19 epidemic in Bangladesh: Good, bad or ugly?
Siam, Z. S., Arifuzzaman, M., Rashid, M. H., islam, m. s.
10.1101/2020.10.21.20216812 — Posted: 2020-10-23
An Empirical Inference of the Severity of Resurgence of COVID-19 in Europe
Baruah, H. K.
10.1101/2020.10.21.20213868 — Posted: 2020-10-23
Viral dynamics of SARS-CoV-2 infection and the predictive value of repeat testing
Kissler, S. M., Fauver, J. R., Mack, C., Tai, C., Shiue, K. Y., Kalinich, C., Jednak, S., Ott, I., Vogels, C., Wohlgemuth, J., Weisberger, J., DiFiori, J., Anderson, D. J., Mancell, J., Ho, D., Grubaugh, N. D., Grad, Y. H.
10.1101/2020.10.21.20217042 — Posted: 2020-10-23 Discussion: Onsite | Offsite
Superspreading Events Without Superspreaders: Using High Attack Rate Events to Estimate N o forAirborne Transmission of COVID-19
PRENTISS, M. G., Chu, A., Berggren, K. K.
10.1101/2020.10.21.20216895 — Posted: 2020-10-23 Discussion: Onsite
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1)
Jogi, P., Soeorg, H., Ingerainen, D., Soots, M., Lattekivi, F., Naaber, P., Toompere, K., Peterson, P., Haljasmagi, L., Zusinaite, E., Vaas, H., Pauskar, M., Shablinskaja, A., Kaarna, K., Paluste, H., Kisand, K., Oona, M., Janno, R., Lutsar, I.
10.1101/2020.10.21.20216820 — Posted: 2020-10-23
Survey of Attitudes on Personal Protection Interventions Against COVID-19 Including MMR Vaccination and Future Anti-COVID Vaccines
Schulman, J. D., Cooper, J. N., Crooks, G. W.
10.1101/2020.10.21.20215251 — Posted: 2020-10-23
Comparison of three nasopharyngeal swab types and the impact of physiochemical properties for optimal SARS-CoV-2 detection
Kahamba, T. R., Noble, L., Scott, L., Stevens, W.
10.1101/2020.10.21.20206078 — Posted: 2020-10-23
Serological surveillance of SARS-CoV-2: trends and humoral response in a cohort of public health workers
Harris, R. J., Whitaker, H. J., Andrews, N. J., Aiano, F., Amin-Chowdhury, Z., Flood, J., Borrow, R., Linley, E., Ahmad, S., Stapley, L., Hallis, B., Amirthalingam, G., Parker, B., Horsley, A., Brooks, T. J. G., Brown, K., Ramsay, M., Ladhani, S.
10.1101/2020.10.21.20216689 — Posted: 2020-10-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).